Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care

Circulating tumor DNA (ctDNA), accurately described by the term liquid profiling (LP), enables real-time assessment of the tumor mutational profile as a minimally invasive test and has therefore rapidly gained traction, particular for the management of cancer patients. By LP, tumor-specific genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Haselmann, Verena, Hedtke, Maren, Neumaier, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947441/
https://www.ncbi.nlm.nih.gov/pubmed/35328301
http://dx.doi.org/10.3390/diagnostics12030748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947441/
https://www.ncbi.nlm.nih.gov/pubmed/35328301
http://dx.doi.org/10.3390/diagnostics12030748

Ejemplares similares